The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


European registry data on LAA closure: advancing the field of interventional stroke prevention

EuroIntervention 2018;14:135-138. DOI: 10.4244/EIJV14I2A20

Cardiologicum Hamburg, Hamburg, Germany

Five-year data from randomised trials comparing left atrial appendage (LAA) closure employing the WATCHMAN® device (Boston Scientific, Marlborough, MA, USA) to warfarin for stroke prevention in patients with atrial fibrillation (AFib) have shown non-inferiority and a net benefit for patients; in fact mortality as well as stroke severity was lower in the device group1. However, current ESC guidelines only give a IIb B recommendation for LAA closure in patients with increased bleeding risk. Prospective registry data from Europe now give us new insights into the benefits and risks of this procedure.

Previously, certain anatomies were believed not to ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
No-reflow after percutaneous coronary intervention: a correlate of poor outcome in both persistent and transient forms